Inverse effect of mucinous component on survival in stage III colorectal cancer

12Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background Although mucinous adenocarcinoma (MAC) is has been recognized as a separate entity in colorectal cancer (CRC), adenocarcinoma with a mucinous component (ACM) remains poorly understood. Methods The association of MAC and ACM with disease-free survival (DFS) and overall survival (OS) was examined using the Cox proportional hazard model in 425 consecutive stage III CRCs. Results Compared with conventional adenocarcinoma (CAC), patients with MAC exhibited independently worse DFS (hazard ratio [HR], 2.64; 95% CI, 1.21-5.80; P=0.014) and OS (HR, 3.56; 95% CI, 1.53-8.30; P=0.003). Unexpectedly, ACM was significantly associated with worse OS than CAC (P=0.002), despite having a similar DFS to CAC. Further, ACM patients after recurrence exhibited significantly worse OS than CAC patients (P<0.001), similar to MAC. Conclusions Although ACM is similar to CAC with regard to estimated risk of recurrence, the outcome is extremely poor once recurrence occurs and is identical to MAC; one of the most aggressive phenotypes of stage III CRC. Thus, both MAC and ACM are adverse prognostic factors for OS. J. Surg. Oncol. 2014 110:851-857.

Cite

CITATION STYLE

APA

Ooki, A., Akagi, K., Yatsuoka, T., Asayama, M., Hara, H., Yamamoto, G., … Yamaguchi, K. (2014). Inverse effect of mucinous component on survival in stage III colorectal cancer. Journal of Surgical Oncology, 110(7), 851–857. https://doi.org/10.1002/jso.23742

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free